Valuation: Perrigo Company

Market Cap 2.31B 2.05B 1.9B 1.73B 3.26B 219B 3.32B 22.85B 8.96B 114B 8.66B 8.48B 364B P/E 2026 *
1,663x
P/E 2027 * 13.9x
Enterprise Value 5.21B 4.63B 4.29B 3.91B 7.37B 495B 7.49B 51.62B 20.24B 258B 19.56B 19.15B 823B EV / Sales 2026 *
1.28x
EV / Sales 2027 * 1.25x
Free-Float
99.61%
Yield 2026 *
6.96%
Yield 2027 * 7.14%
Manager TitleAgeSince
Chief Executive Officer 63 07/06/2026
Director of Finance/CFO 51 16/05/2022
Chief Operating Officer - 23/06/2025
Director TitleAgeSince
Director/Board Member 75 01/11/2014
Director/Board Member 61 07/11/2016
Director/Board Member 70 06/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%+6.59%+53.41%+103.85% 1,120B
+0.90%-2.25%+33.02%+62.23% 616B
+0.71%+3.24%+25.81%+93.86% 504B
-0.13%+5.98%+32.91%+50.39% 367B
+0.52%+0.24%+73.92%+40.15% 360B
-0.95%+4.70%+19.51%+43.00% 288B
-1.98%+3.73%-0.86%+13.43% 258B
-0.35%+4.25%+46.21%+50.76% 234B
-0.75%+3.32%+32.53%+97.21% 194B
Average -0.18%+3.61%+35.16%+61.65% 437.88B
Weighted average by Cap. +0.13%+3.83%+39.18%+71.44%

Financials

2026 *2027 *
Net sales 4.06B 3.61B 3.34B 3.04B 5.74B 385B 5.83B 40.2B 15.76B 201B 15.24B 14.91B 641B 4.09B 3.63B 3.37B 3.07B 5.78B 388B 5.88B 40.5B 15.88B 203B 15.35B 15.02B 646B
Net income -224M -199M -185M -168M -317M -21.27B -322M -2.22B -870M -11.1B -841M -823M -35.38B -56.95M -50.62M -46.92M -42.69M -80.56M -5.4B -81.85M -564M -221M -2.82B -214M -209M -8.99B
Net Debt 2.9B 2.58B 2.39B 2.18B 4.11B 276B 4.17B 28.77B 11.28B 144B 10.9B 10.67B 459B 2.78B 2.47B 2.29B 2.09B 3.94B 264B 4B 27.57B 10.81B 138B 10.45B 10.22B 440B
Logo Perrigo Company
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Perrigo Company